File:Evolvement of the assessment of nature-derived inventions in U.S. Patent System.png
Size of this preview: 621 × 600 pixels. Other resolutions: 249 × 240 pixels | 497 × 480 pixels | 701 × 677 pixels.
Original file (701 × 677 pixels, file size: 182 KB, MIME type: image/png)
 | This is a file from the Wikimedia Commons. Information from its description page there is shown below. Commons is a freely licensed media file repository. You can help. |
Summary
Evolution of the patent eligibility practice of nature-derived inventions in U.S. Patent System. Note: the red arrows demonstrate major policy shifts. CCBY license from: Althabhawi, N.M.; Zainol, Z.A. The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability. Biomolecules 2022, 12, 124. https://doi.org/10.3390/biom12010124
Licensing
This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 16:41, 8 May 2023 | | 701 × 677 (182 KB) | Walter Tau | Evolvement of the assessment of nature-derived inventions in U.S. Patent System. Note: the red arrows demonstrate the transformation from phase to phase. CCBY license from: Althabhawi, N.M.; Zainol, Z.A. The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability. Biomolecules 2022, 12, 124. https://doi.org/10.3390/biom12010124 |
File usage
The following page uses this file:
